Study to Evaluate KarXT as a Treatment for Psychosis Associated with Alzheimer’s Disease
Estado:
A recrutar
Research Area
Treatment for Psychosis Associated with Alzheimer’s Disease.
Resumo
To evaluate the safety and efficacy of KarXT for the treatment of psychosis associated with Alzheimer’s disease.
Candidatos
People aged between 55 and 90 years with possible or probable Alzheimer’s disease and the presence of psychotic symptoms for ≥2 months prior to the first study assessment visit.
